we are offering mdai - 5,6-methylenedioxy-2 aminoindane.
5,6-methylenedioxy-2-aminoindane (mdai) is a drug developed in the 1990s by a team led by david e. nichols at purdue university. it acts as a non-neurotoxic and highly selective serotonin releasing agent (ssra) in vitro and produces entactogen effects.
we are offering mdai - 5,6-methylenedioxy-2 aminoindane.
5,6-methylenedioxy-2-aminoindane (mdai) is a drug developed in the 1990s by a team led by david e. nichols at purdue university. it acts as a non-neurotoxic and highly selective serotonin releasing agent (ssra) in vitro and produces entactogen effects.
Secondary Business TypeManufacturer / Exporters / Wholesale Suppliers
Year of Establishment1983
No. of Employees51 - 100
Annual TurnoverRs. 300 to 400 Crore Approx.
Ownership TypeCorporation/Limited Liability Company
Opening Hours
SUN : Closed
MON : 9:30 AM - 6:30 PM
TUE : 9:30 AM - 6:30 PM
WED : 9:30 AM - 6:30 PM
THU : 9:30 AM - 6:30 PM
FRI : 9:30 AM - 6:30 PM
SAT : 9:30 AM - 6:30 PM
Harleystreet Pharmaceuticals Limited, with its inception barely 26 years back 1985 has today evolved into a fully integrated, healthcare group, marking its presence in India.